
Clinical
Development
Regulatory
Strategy
Pharmacology
Pharmacovigilance
Clinical
Operations
Biostatistics
Collective Intelligence
Cross-functional collaboration enables an integrated strategy and design that maximizes the probability of success
Collaborate.
Build.
Succeed.
The Power of our Team
'The team has moved with remarkable speed to secure ELV001 and prepare it for later stage clinical trials'
PARTNER AT SOFINNOVA


>75%
MD/PhDs


>500
Clinical trials across collective track record


>50
Approved drugs across collective track record
Leaders by Function


Clinical Development

Biostatistics

Clinical Operations

Clinical Pharmacology

Pharmacovigilance

Regulatory

Strategy


Clinical Development

Biostatistics

Clinical Operations

Clinical Pharmacology

Pharmacovigilance

Regulatory

Strategy
Clinical Development
Engineering data-driven development trajectories through to proof-of-concept success
Clinical Development
Engineering data-driven development trajectories through to proof-of-concept success
Business
Leaders

Houman Ashrafian
MD PhD
Co-founder &
Chairman
"Smart drug development is about effectively navigating risk in an ever-changing environment."
x
x

Emma Tinsley
Co-founder &
CEO
"Clinical trials don't have to fail at the rate they do - the real problem is how poorly we understand and manage risk."
x

Duncan McHale
MD PhD
Co-founder &
VP Clinical Development
"Combining our proprietary AI tools with clinical science and development experience will bring new therapies to patients and value to biotech companies faster than ever.”

Bryony Harraway
SVP Head of Finance &
Operations
"There’s a strong scientific backbone to everything we do, harnessing the best clinical minds to deliver evidence-driven, high‑quality clinical input that will make a genuine difference to patients."
x

Andrea Sotak
SVP Head of Corporate
Development & Strategy
"Great strategy in biotech comes from aligning scientific potential with commercial reality and making clear, evidence-based decisions that maximize asset value at every stage of development."

Philippa Egerton-Warburton
VP Head of
Business Development
"Expert-in-the-loop is now how smart drug development is done - we actively apply this principle for clients and the new companies we create.”
x
xx
x









